🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to look at the efficacy and safety of Irinotec...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04083235
Treatments Being Tested
The purpose of this study is to characterize the safety of ONIVYDE when use...
Status
Completed
Location
Konyang University Hospital
Start Date
2018-03-08
Trial ID
NCT03446872
Treatments Being Tested
Children, adolescents and young adults with high risk relapsed or treatment...
Status
Completed
Location
University Hospital Regensburg, Department of Pediatric Hematology and Oncology
Start Date
2013-08
Trial ID
NCT01467986
Treatments Being Tested
This multicentric randomized trial will compare the efficacy and safety of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-02-01
Trial ID
NCT06210360
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
This phase II trial studies how well combination chemotherapy works in trea...
Status
Completed
Location
Washington University School of Medicine
Start Date
2013-11-08
Trial ID
NCT01928290
Treatments Being Tested
Unfortunately, despite the best clinical efforts and breakthroughs in biote...
Status
Terminated
Location
Arizona Cancer Center
Start Date
2013-05
Trial ID
NCT01836432
The aim of this study is to compare Onivyde manufactured at two different p...
Status
Completed
Location
Flinders Medical Centre
Start Date
2022-05-30
Trial ID
NCT05383352
To evaluate the safety and tolerability of sotorasib administered in invest...
Status
Active Not Recruiting
Location
Arizona Oncology Associates Professional Corporation
Start Date
2019-12-17
Trial ID
NCT04185883
This is a phase 3, randomized, double-blind, placebo-controlled multi-cente...
Status
Completed
Location
Research Site
Start Date
2009-11-03
Trial ID
NCT00911170
Treatments Being Tested